Trials / Completed
CompletedNCT00002282
A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS
A Randomized Multicenter Study of the Efficacy, Safety, and Toleration of Fluconazole or Clotrimazole Troches in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Not accepted
Summary
To compare the efficacy, safety, and tolerance of fluconazole single daily capsule for 14 days versus clotrimazole troche 5 x daily for 14 days in the treatment of oropharyngeal candidiasis in patients with AIDS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clotrimazole | |
| DRUG | Fluconazole |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2005-06-24
Locations
17 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00002282. Inclusion in this directory is not an endorsement.